Erratum: Baseline serum albumin is a predictive biomarker for patients with advanced pancreatic cancer treated with bevacizumab: A pooled analysis of 7 prospective trials of gemcitabine-based therapy with or without bevacizumab. (Cancer 2014 120 (1780-1786))

S. Pant, L. K. Martin, S. Geyer, L. Wei, K. Van Loon, N. Sommovilla, M. Zalupski, R. Iyer, D. Fogelman, A. H. Ko, T. Bekaii-Saab

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)1154
Number of pages1
Issue number7
StatePublished - Apr 1 2015

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this